Maximizing Productivity and ROI in Modern Clinical Trials The development of new medications is a long, complex, and costly process. Productivity—how efficiently a drug developer creates value from their investment—is key to success, yet it often remains elusive. For pharma and life sciences stakeholders, improving R&D productivity entails balancing clinical outcomes, commercial success, and the […]
Backed by science and real results, Swiss Medica is leading the way in regenerative stem cell therapies with personalized treatments that go beyond symptom management to restore function and quality of life. Neurodegenerative and neurodevelopmental disorders affect millions worldwide—silently progressing, gradually stripping individuals of movement, memory, speech, as well as independence. These conditions, including multiple […]
The world has seen a four-fold rise – in just 30 years — in the number of Type 2 Diabetes cases (880 million according to the WHO 2024 report1) so new drugs (Ozempic, Wegovy) have emerged as novel long-term treatments. DATA SNAPSHOT-USA: According to the CDC, about 34 million Americans have Type 2 Diabetes, while […]
Situation critical – that is where the global fight against Tuberculosis (TB) finds itself at the start of 2025. Millions of people around the world are at risk of contracting and dying of a disease which is often misunderstood as a relic of the past but poses a major threat globally. Today Stop TB Partnership […]
Regenity is leading the regenerative medicine industry, driving growth and innovation to support improved patient care and outcomes. The future of healthcare is promising, with growth and innovation led by advancements in regenerative medicine. Companies like Regenity Biosciences are pioneering advancements in regenerative science and transforming bioabsorbable materials into life-changing solutions. An Explosion of Growth […]
Bioculture was born at the intersection of biodiversity and biomedicine. Today, it is building on its vision of ‘Caring for life’ to contribute to a healthier, more sustainable world Breakthroughs in medical research are helping people live longer, healthier lives. However, the process of developing these lifesaving treatments is long, expensive and sometimes controversial. Biomedical […]
HistoSonics developed the Edison System as a new category of care, delivering non-invasive histotripsy treatment to destroy tumors. Mission By 2050, the CDC expects the total number of new patients diagnosed with liver tumors in the U.S. to increase by almost 50%.1 Current treatments for patients with liver tumors are often invasive, can damage healthy […]
Hevolution Foundation is catalyzing the shift from lifespan to healthspan by advancing the field of geroscience for healthier, longer lives. Aging impacts us all, transcending gender, demographics, and socioeconomic boundaries. While the global population is living longer, these additional years often come with declining health, as chronic illnesses prevent us from living fulfilling later years. […]
M42 is driving healthcare transformation via cutting-edge technologies, including regenerative medicine and personalized treatments. In an era where healthcare costs are escalating, one UAE-based company is disrupting the industry. Enter M42, a first-of-its-kind, tech-enabled health powerhouse, formed in April 2023 and dedicated to shaping the sustainable future of health. Leveraging cutting-edge technologies, M42 focuses on empowering […]
Advancing the role of blood-based cancer screening tests and liquid biopsies in early cancer detection and precision oncology. The Opportunity of Liquid Biopsies with Cancer Care Cancer is the second leading cause of death worldwide, and 10 million deaths in 2020 were attributed to cancer. By 2050, the number of cancer cases is predicted to […]